McFarlane Gordon Inc., the investment dealer subsidiary of Jovian Capital Corp., has acquired the business and assets of Vengate Capital Partners Co. a healthcare investment banking and strategic advisory boutique.

“Vengate represents an important acquisition for McFarlane Gordon, primarily because it gives us a quality team of people that strengthens and expands our research and investment banking activities in the area of biotechnology and healthcare,” said Mark Arthur, McFarlane Gordon CEO, in a release.